Torasemid-Teva (torasemide) tablets 5 mg. №30

Description

Torasemid-Teva (torasemide) tablets 5 mg. №30

Composition

active substance: torasemide;

1 tablet contains torasemide 5 mg or 10 mg;

Excipients: lactose monohydrate, corn starch, sodium starch glycolate (type A), colloidal anhydrous silica, magnesium stearate.

Dosage form

Tablets.

Main physical and chemical properties: white or almost white, round, biconvex tablets with a break line on one side and embossed 915 (for 5 mg tablets) or 916 (for 10 mg tablets) on the other side.

Pharmacotherapeutic group

Diuretics. Highly active diuretics. Simple sulfonamide preparations.
ATX code C0ZS A04.

Pharmacological properties

It is a loop diuretic. In low doses, it has a weak diuretic, saluretic (increase the release of sodium and potassium salts) effect. At a higher dose, increases diuresis (dose-dependent). The main mechanism of the diuretic action is associated with reversible binding to the Na + / 2Cl- / K + cotransporter in the apical section of Henle’s loop, as a result of which renal reabsorption of sodium and chlorine ions is inhibited, the excretion of potassium, magnesium, bicarbonates is stimulated for the second time, and calcium excretion decreases.

Indication:

• essential hypertension;
• swelling and / or effusions caused by congestive heart failure.

Contraindications

You can not appoint Torasemid-Teva tablets 5 mg:

• with intolerance to the components of the drug;
• with intolerance to sulfonylurea preparations;
• with renal failure with anuria;
• with hepatic coma / precoma;
• with arterial hypotension;
• with hypovolemia;
• with hyponatremia;
• with hypokalemia;
• in acute urinary disorders (for example, due to prostate hypertrophy);
• when breastfeeding;
• children.

Application during pregnancy and lactation

During pregnancy, Torasemid-Teva tablets 5 mg is used only for health reasons.
During breastfeeding, this medicine is not used.

Method of administration and dosage

Torasemid-Teva tablets 5 mg is administered orally (inside) on an empty stomach.
For adults, treatment begins with a single dose of 5 mg per day. If the therapeutic effect is insufficient, a single dose is increased to 10 mg. In case of insufficient effectiveness, short-term therapy (up to three days) can be applied using a dose of 20 mg per day.
It is forbidden to exceed the maximum daily dose of 200 mg.
Patients with insufficient liver and / or kidney function need dose adjustment (possibly an increase in the concentration of the active substance in the blood).

Overdose

An overdose of Torasemid-Teva tablets 5 mg may be accompanied by increased diuresis, electrolyte imbalance, drowsiness, amentive syndrome (confusion, incoherence of speech, chaotic movements), symptomatic arterial hypotension, cardiovascular insufficiency, digestive disorders.
Overdose treatment: dose reduction or drug withdrawal, fluid and electrolyte replacement (after appropriate control).

Side effects:

• Metabolic disorders: metabolic alkalosis, muscle spasms, hyperuricemia, hyperglycemia, hypercholesterolemia, hypertriglyceridemia, hypokalemia, disturbances in water and electrolyte balance (hypovolemia, hyponatremia, hypokalemia).
• Cardiovascular disorders: thrombosis, arterial hypotension, cerebral / cardiac ischemia, syncope, angina pectoris, cardiac arrhythmias, acute myocardial infarction.
• Digestive disorders: flatulence, loss of appetite, stomach pain, diarrhea, nausea / vomiting, constipation, pancreatitis.
• Urinary disorders: hypercreatininemia, urinary retention, urge to urinate.
• Hepatobiliary disorders: increased blood levels of γ-glutamyl transpeptidase.
• Hematological disorders: thrombocytopenia, erythrocytopenia, leukocytopenia.
• Dermatological disorders: allergic reactions (exanthema, pruritus, photosensitivity).